United States Biotechnology & Medical Research

LB Pharmaceuticals Inc (LBRX)

Track

Over the past 90 days, LB Pharmaceuticals Inc. recorded one insider transaction involving a proposed sale of 16,500 shares valued at approximately $486,566 by a former officer. This activity follows a period of significant stock price appreciation of 33.9%. The company's last earnings report in May 2026 showed a 3.6% EPS beat.
Ticker: LBRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 9 Jun 2026
Value US$3,497,395.27 | Price 14.93 | Shares 95,208
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-09 PrS Proposed sale
PRENSKY ZACHARY

Former Officer

Officer
95,208
14.93
US$3,497,395 		95,208 14.93 US$3,497,395
2025-09-16 2025-09-12 B Purchase
2.3
Deep Track Biotechnology Master Fund, Ltd.
Large shareholder
69,195 +11.7%
33.72
US$1,008,109 		69,195 +11.7% 33.72 US$1,008,109
2025-09-16 2025-09-12 B Purchase
2.3
Deep Track Biotechnology Master Fund, Ltd.
Large shareholder
761 -3.9%
486.69
US$3,747,751 		761 -3.9% 486.69 US$3,747,751
2025-09-16 2025-09-12 B Purchase
0.6
Nussbaum Ran
Non-Executive Director
1,000,000 +242.9%
15.00
US$15,000,000 		1,000,000 +242.9% 15.00 US$15,000,000
2025-09-16 2025-09-12 B Purchase
0.6
Pontifax Management 4 G.P. (2015) Ltd.
Large shareholder
1,000,000 +242.9%
15.00
US$15,000,000 		1,000,000 +242.9% 15.00 US$15,000,000
2025-09-16 2025-09-12 B Purchase
Vida Ventures GP III, L.L.C.
Large shareholder
767 +60.8%
15.00
US$11,505 		767 +60.8% 15.00 US$11,505
2025-09-16 2025-09-12 B Purchase
Vida Ventures GP III, L.L.C.
Large shareholder
332,566 +60.7%
15.00
US$4,988,490 		332,566 +60.7% 15.00 US$4,988,490
Explore more

More insider trading research around LB Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America